Joseph Cheaib, M.D., PGY-5 at Johns Hopkins Brady Urological Institute recaps research presented at the 2025 Annual Meeting of the American Urological Association, "Survival Outcomes after Surgical Treatment for Non-Clear Cell Renal Cell Carcinoma with Tumor Thrombus Extension: A Population-Based Analysis". Full abstract can be found at https://www.auajournals.org/doi/abs/10.1097/01.JU.0001109704.44053.60.03